Lack of efficacy of infliximab (IFX) in the treatment of primary sclerosing cholangitis (PSC) in inflammatory bowel disease (IBD) in childhood. (8th October 2015) - Cardile, S.; Candusso, M.; Papadatou, B.; Knafelz, D.; Bracci, F.; Pietrobattista, A.; Liccardo, D.; Torre, G.